Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $2.32 billion. The enterprise value is $1.97 billion.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 138.10 million shares outstanding. The number of shares has increased by 13.90% in one year.
| Current Share Class | 138.10M |
| Shares Outstanding | 138.10M |
| Shares Change (YoY) | +13.90% |
| Shares Change (QoQ) | +7.72% |
| Owned by Insiders (%) | 4.37% |
| Owned by Institutions (%) | 68.57% |
| Float | 120.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.91 |
| Forward PS | 9.96 |
| PB Ratio | 3.40 |
| P/TBV Ratio | 3.44 |
| P/FCF Ratio | 242.06 |
| P/OCF Ratio | 37.99 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 205.09 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 1.08.
| Current Ratio | 5.15 |
| Quick Ratio | 4.98 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | 77.17 |
| Interest Coverage | -1.88 |
Financial Efficiency
Return on equity (ROE) is -26.22% and return on invested capital (ROIC) is -6.39%.
| Return on Equity (ROE) | -26.22% |
| Return on Assets (ROA) | -5.86% |
| Return on Invested Capital (ROIC) | -6.39% |
| Return on Capital Employed (ROCE) | -8.76% |
| Revenue Per Employee | $895,253 |
| Profits Per Employee | -$236,402 |
| Employee Count | 609 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $2.40 million in taxes.
| Income Tax | 2.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.68% in the last 52 weeks. The beta is 0.90, so ARWR's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -29.68% |
| 50-Day Moving Average | 13.62 |
| 200-Day Moving Average | 18.68 |
| Relative Strength Index (RSI) | 66.59 |
| Average Volume (20 Days) | 1,834,744 |
Short Selling Information
The latest short interest is 13.24 million, so 9.59% of the outstanding shares have been sold short.
| Short Interest | 13.24M |
| Short Previous Month | 13.53M |
| Short % of Shares Out | 9.59% |
| Short % of Float | 10.95% |
| Short Ratio (days to cover) | 6.34 |
Income Statement
In the last 12 months, ARWR had revenue of $545.21 million and -$143.97 million in losses. Loss per share was -$1.14.
| Revenue | 545.21M |
| Gross Profit | 545.21M |
| Operating Income | -118.55M |
| Pretax Income | -539.92M |
| Net Income | -143.97M |
| EBITDA | -97.43M |
| EBIT | -118.55M |
| Loss Per Share | -$1.14 |
Full Income StatementBalance Sheet
The company has $1.10 billion in cash and $740.51 million in debt, giving a net cash position of $354.80 million or $2.57 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 740.51M |
| Net Cash | 354.80M |
| Net Cash Per Share | $2.57 |
| Equity (Book Value) | 684.23M |
| Book Value Per Share | 4.95 |
| Working Capital | 914.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $61.15 million and capital expenditures -$51.55 million, giving a free cash flow of $9.60 million.
| Operating Cash Flow | 61.15M |
| Capital Expenditures | -51.55M |
| Free Cash Flow | 9.60M |
| FCF Per Share | $0.07 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -21.74% and -26.41%.
| Gross Margin | 100.00% |
| Operating Margin | -21.74% |
| Pretax Margin | -27.93% |
| Profit Margin | -26.41% |
| EBITDA Margin | -17.87% |
| EBIT Margin | -21.74% |
| FCF Margin | 1.76% |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.90% |
| Shareholder Yield | -13.90% |
| Earnings Yield | -6.20% |
| FCF Yield | 0.41% |
Dividend DetailsAnalyst Forecast
The average price target for ARWR is $42.13, which is 150.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.13 |
| Price Target Difference | 150.48% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 199.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
ARWR has an Altman Z-Score of 1.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 3 |